Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Wednesday, March 03, 2021
WuXi AppTec has completed the acquisition of OXGENE, a UK-based contract research and development organization that designs and develops scalable gene therapy technologies.
read more
Wednesday, March 03, 2021
Pharmaron Beijing has entered into a definitive agreement to acquire Allergan Biologics Limited in Liverpool, UK, for US$118.7 million in cash from AbbVie.
read more
AMRI announced that the company has been chosen to support the development and manufacture of lipid excipients for the Pfizer-BioNTech COVID-19 vaccine.
read more
Celonic announced a long-term lease agreement for a new production site and office space spanning 91,500 square feet in the WST-222 building at the Novartis-operated Life Science Park Rheintal.
read more
Friday, February 26, 2021
Catalent and Delphi Genetics have entered into a final and definitive agreement whereby Catalent will acquire 100% of the shares of Delphi Genetics.
read more
Thursday, February 25, 2021
Amyris announced promising preliminary data in a pre-clinical study of its RNA COVID-19 vaccine platform as well as the potential to address current manufacturing, supply scale-up and refrigerated storage and distribution challenges.
read more
Thursday, February 25, 2021
Avid Bioservices announced the initiation of Phase 2 of the company’s two-phase effort to expand the overall manufacturing capacity within its Myford facility.
read more
Wednesday, February 24, 2021
GT Biopharma has signed an expanded GMP manufacturing agreement with Cytovance Biologics for the manufacture of all TriKEs™.
read more
Wednesday, February 24, 2021
MaxiVAX and Minaris Regenerative Medicine GmbH have entered into a manufacturing agreement for MVX-ONCO-2.
read more
Wednesday, February 24, 2021
Within the scope of this partnership, HALIX will provide manufacturing of clinical supply of NovalGen’s therapies.
read more
Monday, February 22, 2021
Wavelength Pharmaceuticals announced the acquisition of a majority stake in Vanamali Organics Pvt. Ltd. of Telangana, India.
read more
Monday, February 22, 2021
Cascade Chemistry announced initiation of construction of new facilities designed to increase the company’s capacity to manufacture APIs under cGMP.
read more
Monday, February 22, 2021
Catalent recently signed a multi-year commercial supply agreement with Aurinia for LUPKYNIS, a drug to treat adult patients with lupus nephritis.
read more
Monday, February 22, 2021
Intravacc announced its new modern pilot production plant will soon be operational.
read more
Friday, February 19, 2021
Cascade Chemistry announced initiation of construction of new facilities designed to increase the company’s capacity to manufacture APIs under cGMP.
read more